Powder Pharms patents expiration
1. Zingo patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5630796 | POWDER PHARMS | Method of delivering powder transdermally with needless injector |
May, 2014
(9 years ago) | |
| US5899880 | POWDER PHARMS | Needleless syringe using supersonic gas flow for particle delivery |
May, 2016
(7 years ago) | |
| US6881200 | POWDER PHARMS | Needleless syringe using super sonic gas flow for particle delivery |
Jun, 2016
(7 years ago) | |
| US6004286 | POWDER PHARMS | Particle delivery |
Mar, 2017
(7 years ago) | |
| US8540665 | POWDER PHARMS | Particle cassettes and processes therefor |
Oct, 2029
(5 years from now) | |
| US9358338 | POWDER PHARMS | Particle cassettes and processes therefor |
Apr, 2035
(11 years from now) | |
| US9370622 | POWDER PHARMS | Devices and methods for delivering particles |
Sep, 2035
(11 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Patient Population(NPP) | Jan 08, 2012 |
Drugs and Companies using LIDOCAINE HYDROCHLORIDE ingredient
Market Authorisation Date: 16 August, 2007
Treatment: Zingo intradermal injection system is a drug delivery system that is capable of delivering fine dry powdered lidocaine hydrochloride monohydrate for local anesthetic action; Zingo is a powder intrader...
Dosage: SYSTEM;INTRADERMAL
More Information on Dosage
ZINGO family patents
